Price loading...

Springer Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
22 April 2011
Listed Since
06 August 2008

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
99% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
96% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.43 01 Mar 2026
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
95% match

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Springer

£109.79 22 Feb 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
95% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£79.70 22 Feb 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
95% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£99.53 25 Feb 2026
Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)
94% match

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

CRC Press

£81.99 01 Mar 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
94% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£134.20 11 Jan 2026
Treatment of Multiple Myeloma and Related Disorders
94% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 27 Feb 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
94% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£146.95 10 Jan 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
94% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£84.59 08 Mar 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
93% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£67.40 09 Mar 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
93% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.41 10 Mar 2026
Myeloma Bone Disease (Current Clinical Oncology)
93% match

Myeloma Bone Disease (Current Clinical Oncology)

Humana

£139.86 21 Feb 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
93% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£104.67 09 Mar 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
93% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£84.27 16 Feb 2026
Horizons in Cancer Research. Volume 73: Volume 73
93% match

Horizons in Cancer Research. Volume 73: Volume 73

£116.24 11 Jan 2026
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
93% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
93% match

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Springer

£110.29 12 Dec 2025
Recent Updates on Multiple Myeloma
93% match

Recent Updates on Multiple Myeloma

IntechOpen

£119.00 10 Mar 2026
Advance in the Treatment of Pediatric Leukemia
92% match

Advance in the Treatment of Pediatric Leukemia

£59.98 08 Mar 2026
Malignant Mesothelioma: 189 (Recent Results in Cancer Research, 189)
92% match

Malignant Mesothelioma: 189 (Recent Results in Cancer Research, 189)

Springer

£84.46 28 Feb 2026
Springer Prevention of Bone Metastases - Cancer Research 192
92% match

Springer Prevention of Bone Metastases - Cancer Research 192

Springer

£102.86 01 Mar 2026
Prevention of Bone Metastases: 192 (Recent Results in Cancer Research, 192)
92% match

Prevention of Bone Metastases: 192 (Recent Results in Cancer Research, 192)

Springer

£64.88 01 Mar 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
92% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£147.52 10 Jan 2026